Eric R. Lutz

Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi et al. · Journal of Clinical Oncology · 2015 · 588 citations · Full text

Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis

Takahiro Tsujikawa, Sushil Kumar, Rohan N. Borkar et al. · Cell Reports · 2017 · 585 citations · Full text

Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer

Dung T. Le, Eric R. Lutz, Jennifer N. Uram et al. · Journal of Immunotherapy · 2013 · 547 citations · Full text

Immunology, Gm-csf Gene, Immune Cell Therapy +19

Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation

Eric R. Lutz, Annie A. Wu, Elaine Bigelow et al. · Cancer Immunology Research · 2014 · 521 citations · Full text

Immunology, Immune Regulation, Pathology +18

A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells

Paul E. Zarek, Ching-Tai Huang, Eric R. Lutz et al. · Blood · 2007 · 490 citations · Full text